Inhaled therapy may shield heart during stent surgery
NCT ID NCT07397351
First seen Feb 09, 2026 · Last updated May 22, 2026 · Updated 14 times
Summary
This study tests whether an inhaled medication called Aroxxen® can reduce heart muscle damage in people undergoing a common procedure to open blocked heart arteries (stent placement). About 180 adults with coronary artery disease will receive either Aroxxen® inhalation or standard care. Researchers will measure heart damage markers in the blood and check for side effects to find the best dose and treatment length.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City Multidisciplinary Hospital No. 2
RECRUITINGSaint Petersburg, Russia
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.